As of April 2024 Mirati Therapeutics has a market cap of $4.11 Billion. This makes Mirati Therapeutics the world's 2928th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $4.11 B | -0.09% |
2023 | $4.12 B | 57.94% |
2022 | $2.60 B | -67.81% |
2021 | $8.10 B | -26.59% |
2020 | $11.04 B | 116.88% |
2019 | $5.09 B | 268.92% |
2018 | $1.38 B | 167.82% |
2017 | $0.51 B | 444.58% |
2016 | $94.63 M | -84.47% |
2015 | $0.60 B | 142.52% |
2014 | $0.25 B | 12.36% |
2013 | $0.22 B | 154.86% |
2012 | $87.74 M | 28.97% |
2011 | $68.03 M | 1102.3% |
2010 | $5.65 M | -48.91% |
2009 | $11.07 M |
On Apr 23rd, 2024 the market cap of Mirati Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
TravelCenters of America TA | $1.29 B | -68.46% | ๐บ๐ธ USA |
Nymox Pharmaceutical NYMX | $18.25 M | -99.56% | Bahamas |